Zazel-Chavah O'Garra, a brain tumor survivor and former dancer, refuses to let her disability define her. She now works as a social worker and inspires others through her dance company for disabled ...

On Saturday morning, the 20-year old college sophomore will be kicking off the first steps of her first road race — the Shamrock 8K at the Virginia Beach Oceanfront.

FDA approval extends nivolumab into first-line stage III/IV cHL in adults and pediatrics, following priority review of the supplemental application for nivolumab plus AVD. SWOG S1826 showed superior ...

Curis, a biotechnology company dedicated to delivering innovative cancer treatments, has made significant strides in its mission to improve the lives of patients with lymphoma and leukemia. In their ...

Curis, Inc. (NASDAQ:CRIS) Q4 2025 Earnings Call Transcript March 19, 2026 Curis, Inc. misses on earnings expectations. Reported EPS is $-0.5 EPS, expectations were $-0.436. Operator: Good afternoon, ...

Abstract: Brain-computer interface (BCI) is a rapidly evolving technology that has the potential to widely influence research, clinical and recreational use. Non-invasive BCI approaches are ...

James Dentzer, President and CEO, stated that "we continue to make steady progress in our TakeAim Lymphoma study in primary CNS lymphoma, one of the most rare and most difficult to treat of the NHL ...

A treatment regimen of penpulimab combined with rituximab, high-dose methotrexate, and cytarabine (Pen-RMA) achieved its primary endpoint in newly diagnosed primary central nervous system lymphoma ...

HealthDay News — Features that characterize presentation of vitreoretinal lymphoma are described in an article published online March 1 in Clinical & Experimental Ophthalmology.

Readers will learn how veterinary oncologists stage and treat canine lymphoma using modern multi-agent chemotherapy and palliative care.

Interim phase 1b data showed 100% partial response rate in efficacy-evaluable CLL/SLL (4/4) after a median of at least three prior treatment lines. In heavily pretreated MZL (n=5), three complete ...

Debi Weiss was annoyed but not concerned when she started feeling weak and out of breath in January 2024. She thought it was ...